Código QR (código de barras bidimensional)

Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo

Abstract Glucagon-like peptide 1 receptor (GLP-1R) agonist is an emerging anti-diabetic medication whose effects on the risk and progression of cholangiocarcinoma (CCA) are controversial. This study aimed to elucidate the roles of GLP-1R and its agonists on intrahepatic CCA (iCCA) progression. Expre...

Fuld beskrivelse

Na minha lista:
Principais autores: Ronnakrit Trakoonsenathong, Waritta Kunprom, Chaiwat Aphivatanasiri, Padcharee Yueangchantuek, Paslada Pimkeeree, Supannika Sorin, Kullanat Khawkhiaw, Ching-Feng Chiu, Seiji Okada, Sopit Wongkham, Charupong Saengboonmee
Format: Artigo
Sprog:Inglês
Udgivet: Nature Portfolio 2024-06-01
Serier:Scientific Reports
Fag:
Cholangiocarcinoma
Diabetes mellitus
Glucagon-like peptide 1 receptor
Liraglutide
Online adgang:https://doi.org/10.1038/s41598-024-64774-2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker